Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Journal of the National Cancer Institute
|
February 14, 2022
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium
Quisette P Janssen, Jacob L van Dam, Deesje Doppenberg, et al.
American Journal of Surgery
|
May 24, 2024
Postoperative pain scores and opioid use after standard bupivacaine vs. liposomal bupivacaine regional blocks for abdominal cancer surgery: A propensity score matched study
Artem Boyev, Keyuri Popat, Vijaya N R Gottumukkala, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
July 19, 2023
Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy
Artem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Cancer Medicine
|
July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Chirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Annals of Surgery
|
January 17, 2023
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma
Timothy E Newhook, Timothy J Vreeland, James F Griffin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Quisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study
Esther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
Molecular Metabolism
|
December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop
Yihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancers
|
October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Journal of the National Cancer Institute
|
February 14, 2022
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium
Quisette P Janssen, Jacob L van Dam, Deesje Doppenberg, et al.
American Journal of Surgery
|
May 24, 2024
Postoperative pain scores and opioid use after standard bupivacaine vs. liposomal bupivacaine regional blocks for abdominal cancer surgery: A propensity score matched study
Artem Boyev, Keyuri Popat, Vijaya N R Gottumukkala, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
July 19, 2023
Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy
Artem Boyev, Laura R Prakash, Yi-Ju Chiang, et al.
Cancer Medicine
|
July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Chirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Annals of Surgery
|
January 17, 2023
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma
Timothy E Newhook, Timothy J Vreeland, James F Griffin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2022
Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
Quisette P Janssen, Jacob L van Dam, Laura R Prakash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study
Esther N Dekker, Jacob L van Dam, Quisette P Janssen, et al.
Molecular Metabolism
|
December 31, 2021
CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop
Yihui Chen, Michela Capello, Mayrim V Rios Perez, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
Cancers
|
October 16, 2024
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, et al.
Page
of 7